Frederick J Raal
Frederick J Raal is an expert in Cardiology at University of the Witwatersrand (South Africa). As of October 2026, ScienceLeadR ranks Frederick J Raal in the top 1% of experts worldwide for Hypercholesterolemia, Hyperlipidemias and Dyslipidemias. Frederick J Raal has authored 471 publications, the most recent in 2026, and is an investigator in 23 clinical trials. SLR score: 2,085 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Biochemistry - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Frederick J. Raal, MBBCh (cum laude), FRCP, FRCPC, FCP(SA), Cert Endo, MMED, PhD, DSC
Director, Carbohydrate and Lipid Metabolism Research Unit Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Professor Raal is a Distinguished Professor in the Division of Endocrinology and Metabolism, as well as Director of the Carbohydrate and Lipid Metabolism Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
He is a NRF A-rated scientist and has authored or co-authored over 400 original articles and book chapters and has reviewed for several international journals including the New England Journal of Medicine, the Lancet, Circulation, and Atherosclerosis. He is on the Editorial Board of Atherosclerosis, a co-editor for Current Opinion in Lipidology and is a Board member of the International Atherosclerosis Society.
Professor Raal is particularly interested in lipids and lipid disorders and has been integrally involved in the management of familial dyslipidaemia, particularly heterozygous and homozygous familial hypercholesterolaemia (FH). The major focus of his research remains the clinical, biochemical, genetic and therapeutic management of this condition and he continues to conduct studies with novel therapies such as PCSK9-inhibitors and ANGPTL3-inhibitors in this patient group.
Organizations
Career arc: 1985 - 2026
Number : 471
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Reducing LDL-Cholesterol Burden in Homozygous Familial Hypercholesterolemia: The Earlier, The Lower, The Longer, The Better. PMID 42954708 — hyperlipoproteinemia type ii, cholesterol, ldl, cholesterol, atherosclerosis, hypercholesterolemia, homozygous familial hypercholesterolemia | JACC Case Rep | 2026 | 0 |
| Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry. PMID 42149947 — registries, cholesterol, ldl, lipoproteins, cardiovascular diseases, cardiology, cholesterol, sex, diagnosis, therapeutics | Eur Heart J Top journal | 2026 | 0 |
| Lipoprotein(a)-dependent cardiovascular risk in different populations: are thresholds the same? PMID 42856082 — lipoproteins, cohort studies, lipoprotein(a) | Ann Med | 2026 | 0 |
| Serum lipids and outcomes of COVID-19 patients admitted to a tertiary hospital in Johannesburg, South Africa. PMID 42563655 — tertiary care centers, fasting, mortality, cholesterol, ldl, serum, lipoproteins, hospital mortality, cholesterol, covid-19, intensive care units, ventilation, plasma | S Afr Med J | 2026 | 0 |
| Andes virus associated hantavirus cardiopulmonary syndrome and repurposing lipid medications to calm down the cytokine storm. PMID 42468739 — cytokines, ezetimibe, cytokine release syndrome, orthohantavirus, viruses, satellite viruses, hydroxymethylglutaryl-coa reductase inhibitors, communicable diseases | Int J Infect Dis | 2026 | 0 |
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map